Author

Anaïs Boisson

Institut Jules Bordet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Christelle BouchartiD· 1 shared Dirk Van GesteliD· 1 shared Eric QuertinmontiD· 1 shared Ilse RoomaniD· 1 shared Jean‐Baptiste BachetiD· 1 shared Jean‐Luc Van LaethemiD· 1 shared Julie NaveziD· 1 shared Karen E Willard-GalloiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Christelle BouchartORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy

Christelle Bouchart, Oier Azurmendi Senar, Julie Navez, Laurine Verset, Anaïs Boisson, Matthieu Hein, Kosta Stosic, Eric Quertinmont, Vjola Tafciu, Shulin Zhao, Léo Mas, Nicky D’Haene, Dirk Van Gestel, Luigi Moretti, Ilse Rooman, , Jean‐Luc Van Laethem

This study shows that combining FOLFIRINOX with stereotactic body radiotherapy remodels pancreatic ductal adenocarcinoma, improving stromal and metabolic features and prognosis.

bioRxiv · Apr 30, 2024 · PreprintCancer Biology